Cargando…
Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333927/ https://www.ncbi.nlm.nih.gov/pubmed/37441064 http://dx.doi.org/10.3389/fimmu.2023.1159337 |
| _version_ | 1785070771292340224 |
|---|---|
| author | Meringa, A. D. Hernández-López, P. Cleven, A. de Witte, M. Straetemans, T. Kuball, J. Beringer, D. X. Sebestyen, Z. |
| author_facet | Meringa, A. D. Hernández-López, P. Cleven, A. de Witte, M. Straetemans, T. Kuball, J. Beringer, D. X. Sebestyen, Z. |
| author_sort | Meringa, A. D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10333927 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103339272023-07-12 Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies Meringa, A. D. Hernández-López, P. Cleven, A. de Witte, M. Straetemans, T. Kuball, J. Beringer, D. X. Sebestyen, Z. Front Immunol Immunology Frontiers Media S.A. 2023-06-27 /pmc/articles/PMC10333927/ /pubmed/37441064 http://dx.doi.org/10.3389/fimmu.2023.1159337 Text en Copyright © 2023 Meringa, Hernández-López, Cleven, de Witte, Straetemans, Kuball, Beringer and Sebestyen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Meringa, A. D. Hernández-López, P. Cleven, A. de Witte, M. Straetemans, T. Kuball, J. Beringer, D. X. Sebestyen, Z. Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies |
| title | Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies |
| title_full | Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies |
| title_fullStr | Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies |
| title_full_unstemmed | Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies |
| title_short | Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies |
| title_sort | strategies to improve γδtcrs engineered t-cell therapies for the treatment of solid malignancies |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333927/ https://www.ncbi.nlm.nih.gov/pubmed/37441064 http://dx.doi.org/10.3389/fimmu.2023.1159337 |
| work_keys_str_mv | AT meringaad strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT hernandezlopezp strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT clevena strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT dewittem strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT straetemanst strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT kuballj strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT beringerdx strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies AT sebestyenz strategiestoimprovegdtcrsengineeredtcelltherapiesforthetreatmentofsolidmalignancies |